synced 9 MIN AGO
01 Record

CVE-2022-2197

Exemys RME1

CriticalPUBLISHEDCNA: icscert
CNA base score9.8 CVSS v3.xCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

02 Description

Exemys RME1

03 Exploitation and scoring

Exploitation
Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.
SSVC decision
  • ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
  • AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
  • Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.
CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.
EPSS probability
1.54% probability of exploitation activity in the next 30 days.
EPSS percentile
Equal to or higher than the score of 74.7% of scored records. A rank, not a probability.
NVD base score
9.8 (CVSS v3.x), scored by the NVD independently of the CNA.
NVD CVSS vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
NVD analysis status
Modified. NVD last modified this record on 2026-06-17.
Red Hat severity
No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

04 Metadata

Published
2022-06-30 18:42Z4 YR AGO
Last updated
2025-04-16 16:15Z1 YR AGO
Reserved
2022-06-24
Assigning CNA
icscert
Record state
PUBLISHED
Severity
Critical (CVSS 9.8)
CNA CVSS vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Weaknesses
  • CWE-287Improper AuthenticationClass
Data version
5.1
Document digest
9bf17d1698e7a53a814d646fe2ddc67d4fa93159364e13627b370526cfe724b2

05 Affected products

VendorProductVersionsPlatforms
ExemysRME1-AI firmwareAll versions to 2.1.6—

06 References

07 Remediation

Exemys no longer sells or maintains RME1 and considers it to be an end-of-life product. Exemys recommends updating to a new supported product in RME2. For more information on upgrading, contact Exemys support.